SAN DIEGO – The rapidly expanding therapeutic landscape of glucagon-like peptide-1 (GLP-1) receptor agonists, widely recognized for their transformative impact…
Read More
GLP-1 Receptor Agonists and the Emerging Question of Anticancer Effects
The rapidly expanding landscape of drugs designed to mimic glucagon-like peptide-1 (GLP-1), famously exemplified by Ozempic and Wegovy, is increasingly…
Read More
Unlocking the Genetic Keys to GLP-1 Drug Efficacy and Side Effects
A groundbreaking study involving over 23andMe customers has identified genetic variations in two key genes that significantly influence both the…
Read More
Unlocking the Brain’s Secret Role in Metformin’s Anti-Diabetic Effects: A New Frontier in Metabolic Research
For more than six decades, metformin has served as the cornerstone of pharmacological management for type 2 diabetes. Since its…
Read More
Breakthrough Research Reveals the Brain as a Primary Driver of Metformin’s Anti-Diabetic Effects through Rap1 Signaling
For more than six decades, metformin has served as the foundational pharmacotherapy for the management of type 2 diabetes, a…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Discusses Screwworm, Shingles Vaccine’s Anti-Aging Effects, and Current Public Health Data
In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…
Read MoreYOU MAY HAVE MISSED
